How do acei work
Pro Research Analysisby 
Searched over 200M research papers
Mechanisms of Action of ACE Inhibitors (ACEi)
Introduction to ACE Inhibitors
Angiotensin-converting enzyme inhibitors (ACEi) are a class of medications primarily used to manage hypertension and heart failure. They function by inhibiting the activity of the angiotensin-converting enzyme (ACE), which plays a crucial role in the renin-angiotensin system (RAS) responsible for regulating blood pressure.
Inhibition of Angiotensin II Production
Conversion of Angiotensin I to Angiotensin II
ACE is responsible for converting angiotensin I into angiotensin II, a potent vasoconstrictor that increases blood pressure. By inhibiting ACE, ACEi reduce the production of angiotensin II, leading to vasodilation and a subsequent decrease in blood pressure 15.
Impact on Bradykinin
ACE also degrades bradykinin, a peptide that promotes vasodilation. Inhibition of ACE results in increased levels of bradykinin, further contributing to the vasodilatory effects and lowering blood pressure .
Upregulation of ACE2
Counterbalancing Angiotensin II
Emerging evidence suggests that ACEi can upregulate ACE2, an enzyme that converts angiotensin II into angiotensin (1-7), which has vasodilatory and anti-inflammatory properties. This upregulation helps counterbalance the harmful effects of elevated angiotensin II levels, providing additional antihypertensive benefits .
Improvement of Endothelial Function
Reduction of Vascular Oxidative Stress and Inflammation
ACEi have been shown to improve endothelial function by reducing vascular oxidative stress and inflammation. This improvement is crucial in managing hypertension and preventing cardiovascular disorders, as endothelial dysfunction is an early feature in the pathophysiology of these conditions .
Anti-Fibrotic Effects
Downregulation of TGF-β1 Pathways
ACEi also exhibit anti-fibrotic properties by downregulating the Smad and TGF-β1-activated kinase 1 (TAK1) pathways. This mechanism is particularly beneficial in preventing fibrosis in organs such as the heart, lungs, liver, and kidneys, promoting physiological tissue repair .
Clinical Applications and Benefits
Hypertension and Heart Failure
The primary clinical application of ACEi is in the management of hypertension and heart failure. By reducing the production of angiotensin II and increasing bradykinin levels, ACEi effectively lower blood pressure and reduce the workload on the heart .
Chronic Kidney Disease (CKD)
ACEi are also used in the treatment of chronic kidney disease (CKD) due to their ability to reduce blood pressure and urinary protein excretion. However, their use in advanced CKD stages is still under investigation, with ongoing trials aiming to determine the benefits and risks of ACEi withdrawal in these patients .
Stroke Prevention
There is substantial evidence that ACEi not only lower blood pressure but also provide protective effects on cardiac and cerebral vessels, potentially preventing strokes. This makes ACEi a valuable option in the prevention and treatment of stroke .
Conclusion
ACE inhibitors are a cornerstone in the management of hypertension and heart failure due to their multifaceted mechanisms of action. By inhibiting the conversion of angiotensin I to angiotensin II, increasing bradykinin levels, upregulating ACE2, improving endothelial function, and exhibiting anti-fibrotic properties, ACEi provide comprehensive cardiovascular protection. Ongoing research continues to explore their full potential and optimize their use in various clinical settings.
Sources and full results
Most relevant research papers on this topic